Green John L. 4
4 · Cogent Biosciences, Inc. · Filed Apr 28, 2021
Insider Transaction Report
Form 4
Green John L.
Chief Financial Officer
Transactions
- Sale
Common Stock
2021-04-26$8.86/sh−17,813$157,823→ 3,841 total
Footnotes (2)
- [F1]The shares were sold to cover the Reporting Person's tax liability in connection with the vesting of restricted stock units previously granted to the Reporting Person.
- [F2]The price reported in Column 4 was the weighted-average sale price of the shares. The shares were sold in multiple transactions at prices ranging from $8.80 to $8.90. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the SEC Staff, upon request, full information regarding the number of shares sold at each price within the range set forth herein.